Home / Recalls / Medical Devices
Beckman Coulter Inc. recalls Beckman Coulter Lipase, REF OSR6130 and OSR6230.
Recalled October 30, 2019 · FDA recall Z-0210-2020 · Beckman Coulter
Hazard
NAPQI, a metabolite of Acetaminophen, causes negative interference with the recalled product assays at levels present in the serum/plasma of overdose patients. · FDA Class II
Units
20,926 units
Sold at
Distribution was nationwide. There was government and military distribution. Foreign distribution was made to Canada.
Description
NAPQI, a metabolite of Acetaminophen, causes negative interference with the recalled product assays at levels present in the serum/plasma of overdose patients.
Product
Beckman Coulter Lipase, REF OSR6130 and OSR6230.
Manufacturer(s)
Beckman Coulter Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →